Keywords
Neuromyelitis opticaMedicineNeurologyDermatologyMultiple sclerosisImmunologyPsychiatry
Affiliated Institutions
Related Publications
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Neuromyelitis optica (NMO) is a disabling autoimmune disease associated with an elevation of anti-aquaporin 4 (AQP4) autoantibodies. Here, we present a case with NMO who respond...
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that selectively affects optic nerves and spinal cord. It is considered a severe variant of multiple sclerosi...
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
Our study suggests that IFNβ-1b may trigger severe exacerbation in patients with the NMO spectrum. In INFβ-1b therapy, cases in NMO spectrum should be carefully excluded.
Publication Info
- Year
- 2010
- Type
- article
- Volume
- 12
- Issue
- 3
- Pages
- 244-255
- Citations
- 35
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
35
OpenAlex
Cite This
William M. Carroll,
Kazuo Fujihara
(2010).
Neuromyelitis Optica.
Current Treatment Options in Neurology
, 12
(3)
, 244-255.
https://doi.org/10.1007/s11940-010-0071-z
Identifiers
- DOI
- 10.1007/s11940-010-0071-z